4DMedical Limited (ASX:4DX)
2.100
-0.090 (-4.11%)
Nov 17, 2026, 11:09 AM AEDT
4DMedical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, 4DMedical stock has a consensus rating of "Buy" and an average price target of $4.17. The average 1-year stock price forecast is 98.43% higher than the current stock price, while the lowest is $2.40 (+14.29%) and the highest is $6.00 (+185.71%).
Price Target: $4.17 (+98.43%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for 4DMedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ord Minnett | Ord Minnett | Hold Upgrades $2.40 | Hold | Upgrades | $2.40 | +14.29% | Nov 4, 2026 |
| Jefferies | Jefferies | Hold Maintains $4.10 | Hold | Maintains | $4.10 | +95.24% | Aug 31, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $6.00 | Buy | Maintains | $6.00 | +185.71% | Aug 31, 2026 |
Financial Forecast
Revenue This Year
19.70M
from 7.06M
Increased by 178.98%
Revenue Next Year
51.10M
from 19.70M
Increased by 159.39%
EPS This Year
-0.06
from -0.00
EPS Next Year
-0.03
from -0.06
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.